Nanoparticles of β-cyclodextrin esters obtained by self-assembling of biotransesterified β-cyclodextrins

被引:57
作者
Choisnard, L
Gèze, A
Putaux, JL
Wong, YS
Wouessidjewe, D
机构
[1] Univ Grenoble 1, UFR Pharm, ICMG DPM, CNRS,UMR 5063, F-38243 Meylan, France
[2] CNRS, UPR 5301, Ctr Rech Macromol Vegetales, F-38041 Grenoble 9, France
关键词
D O I
10.1021/bm0507655
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The synthesis of decanoate beta-cyclodextrin esters (beta-CDd) and hexanoate beta-cyclodextrin esters (beta-CDh) was biocatalyzed by thermolysin from native beta-cyclodextrin (beta-CD) and vinyl hexanoate or vinyl decanoate used as acyl donors. The products were chemically characterized by infrared, NMR, and mass spectrometry. Both beta-CDd and beta-CDh esters were identified as a mixture of beta-CD preferentially substituted on the C2 position by the corresponding acyl chain. The degree of substitution varied from 2 to 7 for beta-CDd and from 4 to 8 for beta-CDh. The ability of beta-CD esters to self-organize into nanoparticles was tested using a nanoprecipitation technique in various solvents. The mean size diameter and polydispersity measured by quasi-elastic light scattering were dramatically affected by the nature of solvent (acetone, ethanol, or tetrahydrofuran) used in the nanoprecipitation technique. When directly observed using cryo-transmission electron microscopy, beta-CDh appeared as uniformly dense nanospheres, whereas beta-CDd exhibited a multilamellar onion-like organization. A structural model was rationalized for the beta-CDd nanoparticles.
引用
收藏
页码:515 / 520
页数:6
相关论文
共 32 条
[1]  
AKKARA JA, 2000, Patent No. 063916
[2]  
[Anonymous], 2002, EUROPEAN PHARMACOPEI, V4th
[3]   Micellization of hydrophobically modified cyclodextrins.: 1.: Micellar structure [J].
Auzély-Velty, R ;
Djedaïni-Pilard, F ;
Désert, S ;
Perly, B ;
Zemb, T .
LANGMUIR, 2000, 16 (08) :3727-3734
[4]   Enzymatic production of cyclodextrins [J].
Biwer, A ;
Antranikian, G ;
Heinzle, E .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2002, 59 (06) :609-617
[5]  
Carrea G, 2000, ANGEW CHEM INT EDIT, V39, P2226
[6]  
Choisnard L, 2005, J PHARM PHARM SCI, V8, P593
[7]   Cationic cyclodextrin amphiphiles as gene delivery vectors [J].
Cryan, SA ;
Donohue, R ;
Ravo, BJ ;
Darcy, R ;
O'Driscoll, CM .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2004, 14 (01) :57-62
[8]   Cyclodextrin-based pharmaceutics: Past, present and future [J].
Davis, ME ;
Brewster, ME .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (12) :1023-1035
[9]   Reversible phase transitions in emulsified nanostructured lipid systems [J].
de Campo, L ;
Yaghmur, A ;
Sagalowicz, L ;
Leser, ME ;
Watzke, H ;
Glatter, O .
LANGMUIR, 2004, 20 (13) :5254-5261
[10]   Cationic β-cyclodextrin bilayer vesicles [J].
Donohue, R ;
Mazzaglia, A ;
Ravoo, BJ ;
Darcy, R .
CHEMICAL COMMUNICATIONS, 2002, (23) :2864-2865